2.33

2.92% -0.07

Pre-market: 2.42 0.09 +3.86%

Intelligent Bio Solutions Inc (INBS)

Overview News Price History Financials Why INBS Down? Discussions Forecast Stock Split

Intelligent Bio Solutions Inc stock is traded at $2.33, with a volume of 60,476. It is down -2.92% in the last 24 hours and down -41.90% over the past month. Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Previous Close:

$2.40

Open:

$2.36

24h Volume:

60,476

Relative Volume:

0.52

Market Cap:

$5.57M

Revenue:

$3.91M

Net Income/Loss:

$-11.65M

P/E Ratio:

-0.1891

EPS:

-12.3212

Net Cash Flow:

$-11.51M

1W Performance:

-2.92%

1M Performance:

-41.90%

6M Performance:

-57.64%

1Y Performance:

-87.80%

1-Day Range:

$2.28

$2.41

1-Week Range:

$2.25

$2.42

52-Week Range:

$2.24

$24.90

Intelligent Bio Solutions Inc Stock (INBS) Company Profile

Name

Intelligent Bio Solutions Inc

Sector

Healthcare (1104)

Industry

Medical Devices (141)

Phone

646-790-5756

Address

135 W 41ST ST,, NEW YORK

Employee

Twitter

Next Earnings Date

2026-05-12

Latest SEC Filings

INBS's Discussions on Twitter

Compare INBS vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INBS Intelligent Bio Solutions Inc	2.33	5.57M	3.91M	-11.65M	-11.51M	-12.32
ABT Abbott Laboratories	88.67	154.45B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	307.94	118.05B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	80.38	103.20B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	46.76	69.50B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.28	49.68B	6.30B	1.07B	1.09B	1.8406

Intelligent Bio Solutions Inc Stock (INBS) Latest News

Jun 12, 2026

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine

Jun 12, 2026

Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView

Jun 12, 2026

Jun 11, 2026

INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com

Jun 11, 2026

Jun 09, 2026

INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com

Jun 09, 2026

Jun 06, 2026

Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com

Jun 06, 2026

Jun 05, 2026

INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits

Jun 05, 2026

Jun 04, 2026

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛

Jun 04, 2026

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com

Jun 04, 2026

Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan

Jun 04, 2026

Jun 03, 2026

Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus

Jun 03, 2026

Jun 02, 2026

Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart

Jun 02, 2026

Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks

Jun 02, 2026

Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com

Jun 02, 2026

Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView

Jun 02, 2026

Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan

Jun 02, 2026

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times

Jun 02, 2026

Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan

Jun 02, 2026

INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Stock Declines 3.5%Surprise Factor Analysis - newsline.com

Jun 02, 2026

May 31, 2026

Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com

May 31, 2026

May 29, 2026

INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate

May 29, 2026

May 28, 2026

Intelligent Bio Solutions (INBS) Climbs 4.4% as Shares Test Key Resistance Near $2.71Delta Hedging - newsline.com

May 28, 2026

May 27, 2026

INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com

May 27, 2026

May 26, 2026

Intelligent Bio Solutions (INBS) Surges 7% as Shares Rebound from Support LevelIntraday Trade Ideas - The Legal Advocate

May 26, 2026

May 23, 2026